Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.37 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.37 |
| ▸ | APP | P05067 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | PI4KA | P42356 | 1/20 | 0.34 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18630446 | 0.91 | GPR3 (0.40) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL18942945 | 0.83 | ALDH1A1 (0.56) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL19989725 | 0.83 | ALDH1A1 (0.41) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL19986164 | 0.83 | ADORA2A (0.42) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL15040965 | 0.82 | ALDH1A1 (0.49) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL27017665 | 0.79 | MAPT (0.46) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL24039448 | 0.78 | ALDH1A1 (0.42) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL24039446 | 0.78 | ALDH1A1 (0.40) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL20071418 | 0.77 | ADORA2A (0.43) | ALDH1A1MAPTADORA2ANUDT1MEN1 | |
| SCHEMBL24039150 | 0.77 | MAPT (0.41) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10505126-B2 | Composition for organic optoelectric device and organic optoelectric device and display device | SAMSUNG SDI CO., LTD. (KR) | 2019-12-10 | — | — | US | disclosed |
| US-20180026204-A1 | COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-20180019409-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2018-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180019409-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OR10J3, OR51E2, OXER1 | ALDH1A1 158/4885MAPT 2618/4885HPGD 1323/4885 |
| US-10505126-B2 | Composition for organic optoelectric device and organic optoelectric device and display device | OXER1, OR10J3, OR51E2 | ALDH1A1 156/4885MAPT 2578/4885HPGD 986/4885 |
| US-20180026204-A1 | COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | OXER1, OR10J3, OR51E2 | ALDH1A1 156/4885MAPT 2578/4885HPGD 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.